Skip to main content

Table 2 Some systemic diseases that may lead to progressive cognitive impairment and dementia

From: Early-onset dementias: diagnostic and etiological considerations

System

Examples

Associated symptoms

Diagnostic tests

CNS vascular disease

Primary and secondary CNS vasculitis

Headaches, focal neurological deficits

MRI; cerebral angiography; CSF analysis; brain biopsy; connective tissue disease screen (for example, ANA, C3/C4, RF, c-ANCA and p-ANCA, ENA-4 screen, cryoglobulins)

Infection

HIV-associated neurocognitive disorders Neurosyphilis Whipple's disease

Variable, constitutional symptoms, with or without opportunistic infections Tabes dorsalis Gastrointestinal symptoms, weight loss, and polyarthralgia; oculomasticatory and oculofacial-skeletal myorhythmia in only 20%, but highly specific

HIV screen; plasma HIV viral load; CD4 counts Serum RPR; MHA-TP; CSF VDRL Duodenal biopsy showing granular foamy macrophages with PAS-positive inclusions; CSF PCR for Tropheryma whipplei

Neoplastic

Primary CNS lymphoma

Headaches; focal neurological deficits

CSF analysis; brain/meningeal biopsy

Autoimmune/paraneoplastic

Hashimoto encephalitis

Thyroid abnormalities

Anti-microsomal antibody; anti-thyroglobulin antibody

 

Limbic encephalitis

Cancer (breast, lung, testicular, teratoma colon, gynecological)

Anti-Hu, anti-Ri, anti-Yo, anti-Ma1, anti-Ma2, anti-VGKC, anti-CV2, anti-amphiphysin, anti-NMDAR, anti-AMPAR, anti-GAD antibodies

 

Lupus with CNS involvement

Multiple organ systems

ANA; ENA; CSF analysis; MRI

Endocrine and nutritional

Hypothyroidism

Fatigue, weight gain, skin and hair changes, depression

TSH; free T4

 

B12 Deficiency

Fatigue, macrocytic anemia, 'beefsteak' tongue, subacute combined degeneration of spinal cord

B12

  1. AMPAR, 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic acid receptors; ANA, antinuclear antibodies; ANCA, anti-neutrophil cytoplasmic antibodies; CNS, central nervous system; CSF, cerebrospinal fluid; ENA, extractable nuclear antigens; MHA-TP, microhemagglutination assay; MRI, magnetic resonance imaging; NMDAR, N-methyl-D-aspartate receptors; PAS, periodic acid-Schiff; RF, rheumatoid factor; RPR, Rapid Plasma Reagin; TSH, thyroid stimulating hormone; VDRL, Venereal Disease Research Laboratory test.